The Anatomical and Pathological Characteristics of Irradiated Prostate Cancers May Influence the Oncological Efficacy of Salvage Ablative Therapies
Abstract
Purpose:
Recurrent or radioresistant prostate cancer occurs in approximately 30% of men receiving primary radiotherapy. For men who are candidates for local salvage therapy, the oncological efficacy of ablative therapies may be affected by the anatomical and pathological features of cancers within irradiated prostate glands. We characterized and mapped the prostate cancers in our series of whole mount salvage radical prostatectomy specimens.
Materials and Methods:
A total of 47 salvage radical prostatectomies were performed at our institution between 2000 and 2004. Detailed pathological data, including the anatomical distribution of cancers, were obtained from 46 whole mount salvage radical prostatectomy specimens.
Results:
A total of 70 cancer foci were identified in 46 specimens. Of the specimens 93% had cancer foci at the apex. The median minimum cancer-to-urethra distance was smallest at the apex (4.1 mm) and greatest at the base (13.8 mm). More than 65% of patients had cancer 5 mm or less from the urethra and 7% of patients had cancer directly involving the urethra. Nearly half of all patients had evidence of extraprostatic disease.
Conclusions:
The anatomical and pathological features in our study demonstrate that a significant portion of irradiated cancers are pathologically advanced and distributed in regions of the prostate (apical and periurethral) which are at risk for undertreatment using current ablative therapies. Our findings raise serious concerns regarding the oncological efficacy of such treatment modalities. Long-term studies without the use of hormonal therapy are needed to determine the oncological efficacy of salvage ablative therapies in patients with radiorecurrent or resistant prostate cancer.
References
- 1 : Cancer statistics, 2006. CA Cancer J Clin2006; 56: 106. Google Scholar
- 2 : A nationwide charge comparison of the principal treatments for early stage prostate carcinoma. Cancer2000; 89: 1792. Google Scholar
- 3 : Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA1999; 281: 1598. Google Scholar
- 4 : Prostate cancer and radiation therapy–the message conveyed by serum prostate-specific antigen. Int J Radiat Oncol Biol Phys1995; 33: 23. Google Scholar
- 5 : The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: a survey of practice patterns of urologists and radiation oncologists in the United States. Urology2001; 58: 65. Google Scholar
- 6 : Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys2005; 62: 448. Google Scholar
- 7 : Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels. J Urol1995; 153: 104. Link, Google Scholar
- 8 : The evolution and state of modern technology for prostate cryosurgery. Urology2002; 60: 26. Google Scholar
- 9 : Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology2002; 60: 3. Google Scholar
- 10 : Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer. Int J Urol2006; 13: 228. Google Scholar
- 11 : Current status of local salvage therapies following radiation failure for prostate cancer. J Urol2005; 173: 373. Link, Google Scholar
- 12 : Prostate cryoablation: a scientific rationale for future modifications. Urology2002; 60: 19. Google Scholar
- 13 : Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol2001; 166: 1333. Link, Google Scholar
- 14 : Proximity of prostate cancer to the urethra: implications for minimally invasive ablative therapies. Urology2000; 56: 726. Google Scholar
- 15 : Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol2001; 165: 1937. Link, Google Scholar
- 16 : Incomplete glandular ablation after salvage cryotherapy for recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys2003; 56: 468. Google Scholar
- 17 : Serial histopathology results of salvage cryoablation for prostate cancer after radiation failure. J Urol2003; 170: 1199. Link, Google Scholar
- 18 : Cryosurgical ablation of prostate cancer: patterns of cancer recurrence. J Urol1997; 158: 2206. Link, Google Scholar
- 19 : Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome. J Clin Oncol2002; 20: 2664. Google Scholar
Departments of Urology, Biostatistics/Epidemiology and Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York
